Welcome to our dedicated page for Nexgel SEC filings (Ticker: NXGL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to decode NexGel’s hydrogel business from hundreds of pages of SEC text? When a single factory produces electron-beam cross-linked gels for wound care, drug delivery, and cosmetics, every new 10-K or 8-K can feel like a chemistry paper. Investors want to spot FDA submission timelines, OEM contracts, or how much cash runway remains before the next production scale-up—but those details hide deep in footnotes.
Stock Titan’s AI turns that hunt into a two-minute read. Our platform ingests every NexGel quarterly earnings report 10-Q filing, NexGel insider trading Form 4 transactions, and proxy statement, then delivers plain-English summaries, real-time Form 4 alerts, and key-metric dashboards. Need the latest R&D spend? Click once. Wonder about NexGel executive stock transactions Form 4 ahead of a new cosmetic patch launch? We highlight them instantly. Even 8-K material events—factory upgrades, supply-chain shifts—arrive with context so you understand why they matter.
All filing types are here, updated the moment EDGAR releases them: 10-K annual reports for risk factors and revenue by product line, 10-Q for segment margins, 8-K for material events, Schedule 14A for NexGel proxy statement executive compensation, and every NexGel Form 4 insider transactions real-time. AI-powered summaries explain each note in simple terms, while expert commentary links disclosures to hydrogel capacity, regulatory milestones, and market expansion plans. Whether you search “understanding NexGel SEC documents with AI” or “NexGel earnings report filing analysis,” this page delivers the clarity and speed professionals expect.
Form 144 notice for proposed sale of common stock. The filing shows 35,515 shares of common stock are proposed for sale through The Charles Schwab Corporation, with an aggregate market value of $108,451 and 8,067,580 shares outstanding. The securities were acquired as compensation on 02/15/2024 in a transaction described as "COMPENSATION / DEAL ACQUIRED BETWEEN: 2/15/24 TO 11/5/24" and payment is recorded as of 02/15/2024. The filer reports no securities sold during the past three months. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information.
FAQ
What is the current stock price of Nexgel (NXGL)?
What is the market cap of Nexgel (NXGL)?
